UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):January 12, 2005
Lifecore Biomedical, Inc.
(Exact name of Registrant as specified in its charter)| | | | | |
| Minnesota | | 0-4136 | | 41-0948334 |
| | | | | |
(State or other jurisdiction of
incorporation or organization) | | (Commission File Number) | | (IRS Employer Identification No.) |
| | | |
| 3515 Lyman Boulevard | | |
| Chaska, Minnesota | | 55318 |
| | | |
(Address of principal executive
offices) | | (Zip Code) |
Registrant’s telephone number, including area code:952-368-4300
TABLE OF CONTENTS
Item 2.02 Results of Operation and Financial Condition
On January 12, 2005, Lifecore Biomedical, Inc. (“Lifecore”) issued a press release setting forth Lifecore’s Fiscal 2005 second quarter financial results. A copy of Lifecore’s press release is attached hereto as Exhibit (99.1) and hereby incorporated by reference.
Item 9.01 Financial Statements and Exhibits
(c) The following exhibit is being furnished herewith:
99.1 Press release dated January 12, 2005
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | LIFECORE BIOMEDICAL, INC.
| |
| Dated: January 12, 2005 | | Dennis J. Allingham | |
| | | Dennis J. Allingham | |
| | | President & Chief Executive Officer | |
| |
Exhibit Index
99.1 Press release dated January 12, 2005
